Skip to main content
. 2012 Feb 8;12:63. doi: 10.1186/1471-2407-12-63

Table 2.

Expression of BCA2 and hHR23a in breast cancer cases

Cytoplasmic BCA2 Nuclear BCA2 Cytoplasmic hHR23a Nuclear hHR23a
Variable Low (%) High (%) P-value Low (%) High (%) P-value Low (%) High (%) P-value Low (%) High (%) P-value

ER

Positive 27 (34.2) 52 (65.8) 0.8053 29 (36.7) 50 (63.3) 0.4772 27 (34.2) 52 (65.8) *0.0181 39 (50.0) 39 (50.0) 0.4947

Negative 7 (29.2) 17 (70.8) 11 (45.8) 13 (54.2) 2 (8.3) 22 (91.7) 10 (41.7) 14 (58.3)

PR

Positive 17 (31.3) 39 (68.7) 0.6743 17 (30.4) 39 (69.6) 0.0686 19 (33.9) 37 (66.1) 0.1897 26 (47.3) 29 (52.7) 1.000

Negative 17 (36.1) 30 (63.9) 23 (48.9) 24 (51.1) 10 (21.3) 37 (78.7) 23 (48.9) 24 (51.1)

HER2

Positive 6 (35.3) 11 (64.7) 1.000 8 (47.1) 9 (52.9) 0.5878 5 (29.4) 12 (70.6) 1.000 10 (58.8) 7 (41.2) 0.4292

Negative 28 (32.9) 57 (67.1) 32 (37.6) 53 (62.4) 23 (27.1) 62 (72.9) 39 (46.4) 45 (53.6)

Grade

1 2 (22.2) 7 (77.8) 0.5501 4 (44.4) 5 (55.6) * 0.0297 3 (33.3) 6 (66.7) 0.2730 5 (55.6) 4 (44.4) 0.4142

2 18 (38.3) 29 (61.7) 12 (25.5) 35 (74.5) 14 (29.8) 33 (70.2) 19 (41.3) 27 (58.7)

3 14 (30.4) 32 (69.6) 24 (52.5) 22 (47.8) 12 (26.1) 34 (73.9) 25 (54.3) 21 (45.7)

Nodal

Positive 11 (32.4) 23 (67.6) 1.000 10 (29.4) 24 (70.6) 0.1952 14 (41.2) 20 (58.8) 0.0585 17 (51.5) 16 (48.5) 0.6649

Negative 20 (33.3) 40 (66.7) 26 (43.3) 34 (56.7) 13 (21.7) 47 (78.3) 27 (45.0) 33 (55.0)

* Indicates a correlation which is statistically significant by Fisher's exact t-test or χ2 test